Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report

B-cell lymphomas are neoplastic diseases occasionally associated with chronic inflammation. mRNA vaccines for coronavirus disease 2019 (COVID-19) induce inflammatory responses, which often lead to fever and lymphadenopathies indistinguishable from lymphomas. Although both lymphadenopathies and lymph...

Descripció completa

Dades bibliogràfiques

Autors principals:	Akinori Sekizawa, Kenichi Hashimoto, Shinichi Kobayashi, Sawako Kozono, Takahiro Kobayashi, Yusuke Kawamura, Motohiro Kimata, Naoya Fujita, Yosuke Ono, Yasuhiro Obuchi, Yuji Tanaka
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-08-01
Col·lecció:	Frontiers in Medicine
Matèries:	mRNA vaccine B cell lymphoma COVID-19 lymphadenopathy BNT162b2
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2022.963393/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!